The ?-secretase enzyme (BACE1) is a major current focus for clinical trials in Alzheimer's disease therapy, as BACE1 is the rate-limiting enzyme in APP processing and in the generation of A? and amyloid deposition. We have been interested in how BACE1 enzyme levels are regulated. We have made three unexpected observations. First, the trophic factor BDNF, which is capable of preventing neurodegeneration in mice and humans, increases the transcription of an immediate early gene called Narp. Recent published data indicates that only low levels of Narp are detected in Alzheimer's subjects, suggesting that BDNF and Narp levels are beneficial. Second, Narp binds to BACE1. Experiments are being undertaken to see if the binding of Narp to BACE1 sequesters or alters BACE1 enzymatic activity. Finally, we find that BACE1 enzyme levels in the brain are highly correlated with the expression of the p75 neurotrophin receptor. Many common risk factors for Alzheimer's disease, such as aging, inflammation and hypoxia induce BACE1 activity. The p75 receptor is similarly elevated after nerve injury, seizures and inflammation in the CNS. The p75 receptor is frequently expressed highly during aging in neuronal populations that degenerate in Alzheimer's disease and its expression may reflect an early sign of neurodegeneration. We hypothesize BACE1 levels and its activity is affected by the expression of Narp and p75, two proteins involved in trophic factor action. We intend to test this hypothesis by measuring the amyloidogenic processing of APP, as a function of p75, Narp and BACE1 levels. These studies will determine how the trophic activity and the p75 receptor play either a positive or a negative role after environmental conditions of stress, injury and inflammation. We hypothesize that induction of p75 after brain injury or seizures and the binding of Narp represent regulatory mechanisms associated with BACE1 activity.

Public Health Relevance

We are interested in how trophic factors prevent neurodegeneration. Unexpectedly, we have discovered several new mechanisms that potentially regulate the activity of BACE1, the ??secretase enzyme that produces ? amyloid. Studies on the activity, interactions and regulation of a BDNF-inducible gene, called NARP, and the p75 receptor upon BACE1 will provide new insights into the molecular mechanisms that promote and delay for Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56AG025970-11A1
Application #
9784681
Study Section
Cellular and Molecular Biology of Neurodegeneration Study Section (CMND)
Program Officer
Wise, Bradley C
Project Start
2006-09-30
Project End
2019-08-31
Budget Start
2018-09-30
Budget End
2019-08-31
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
New York University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Mariga, Abigail; Zavadil, Jiri; Ginsberg, Stephen D et al. (2015) Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function. Dev Neurobiol 75:173-92